ClinicalTrials.gg

Program

rotigotine

Also written as “Rotigotine”, “SPM 962” and “Rotigotine transdermal patch”.

Its studies are mostly in Parkinson Disease · Restless Legs Syndrome · Fibromyalgia, led by 5 companies.

Furthest: phase 4, since Dec 21, 200763 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
UCB500 open or runningphase 4since Dec 21, 2007Aug 24, 2005none ahead
Otsuka100 open or runningphase 3since Sep 27, 2007Sep 27, 2007none ahead
Eva Pharma11 open or runningno phasesince May 30, 2025May 30, 2025none ahead
Inflamax Research10 open or runningphase 1since Feb 25, 2016Feb 25, 2016none ahead
Luye Pharma Group10 open or runningphase 1since Mar 31, 2016Mar 31, 2016none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 46 studies since Oct 24, 2005.

  1. Aug 27, 2012Phase 1 study in HealthyUCB · NCT01675024 · 24 enrolled · China
  2. Oct 18, 2012Phase 4 study in Advanced Idiopathic Parkinson's DiseaseUCB · NCT01711866 · 87 enrolled · United States, Korea, Republic of, Malaysia and more
  3. Nov 6, 2012Phase 3 study in Advanced Parkinson's DiseaseUCB · NCT01723904 · 90 enrolled · Australia, Korea, Republic of, Malaysia and more
  4. Dec 5, 2012Phase 4 study in Parkinson DiseaseUCB · NCT01744496 · 68 enrolled · United States, Germany, Poland and more
  5. Jan 3, 2013Phase 1 study in HealthyUCB · NCT01761526 · 50 enrolled · Germany
  6. Jan 30, 2013Phase 4 study in Parkinson DiseaseUCB · NCT01782222 · 122 enrolled · United States, Austria, Hungary and more
  7. May 10, 2013Phase 1 study in HealthyUCB · NCT01854216 · 26 enrolled · Germany
  8. Oct 14, 2013Phase 1 study in Parkinson DiseaseUCB · NCT01964573 · 48 enrolled · Korea, Republic of
  9. Aug 29, 2014Phase 1 study in Parkinson DiseaseUCB · NCT02230904 · 57 enrolled · Germany
  10. Feb 25, 2016Inflamax Research's first study: phase 1 study in Bioequivalence - Irritation and Sensitization Potential of Transdermal PatchNew to Inflamax ResearchInflamax Research · NCT02727205 · 260 enrolled · United States, Canada
  11. Mar 31, 2016Luye Pharma Group's first study: phase 1 study in Parkinson DiseaseNew to Luye Pharma GroupLuye Pharma Group · NCT02728947 · 28 enrolled · United States
  12. Oct 31, 2018Phase 3 study in Restless Legs SyndromeUCB · NCT03728933 · 23 enrolled · United States
  13. Jun 17, 2019Phase 3 study in Restless Legs SyndromeUCB · NCT03992196 · 10 enrolled · United States
  14. May 30, 2025Eva Pharma's first study: no phase study in Parkinson DiseaseNew to Eva PharmaEva Pharma · NCT07015346 · 40 planned

TargetBeta

“D2-like dopamine receptor agonist”ChEMBL 37, by rule

Other programs on the same three targets

ProgramCompanyFurthest phaseStudies
OlanzapineruleEli Lillyphase 476
PramipexoleruleBoehringer Ingelheimphase 444

Studies

The newest 60 of 63 led by companies developing it. Each opens its study page. Every study on its drug page →

StudyPhaseStatusLed byPrimary completionSize
NCT07015346Parkinson Disease–Not yet recruitingEva PharmaOct 15, 202540
NCT03992196Restless Legs Syndrome · United States3TerminatedUCBSep 1, 202210
NCT03728933Restless Legs Syndrome · United States3TerminatedUCBJul 25, 202223
NCT02728947Parkinson Disease · United States1CompletedLuye Pharma GroupAug 201628
NCT02727205Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch · United States, Canada1CompletedInflamax ResearchOct 2013260
NCT02230904Parkinson Disease · Germany1CompletedUCBNov 201457
NCT01964573Parkinson Disease · Korea, Republic of1CompletedUCBFeb 200748
NCT01854216Healthy · Germany1CompletedUCBMar 200326
NCT01782222Parkinson Disease · United States, Austria, Hungary and more4CompletedUCBJan 2014122
NCT01761526Healthy · Germany1CompletedUCBOct 200250
NCT01744496Parkinson Disease · United States, Germany, Poland and more4CompletedUCBDec 201368
NCT01723904Advanced Parkinson's Disease · Australia, Korea, Republic of, Malaysia and more3CompletedUCBMar 201390
NCT01711866Advanced Idiopathic Parkinson's Disease · United States, Korea, Republic of, Malaysia and more4CompletedUCBMar 201387
NCT01675024Healthy · China1CompletedUCBSep 201224
NCT01646268Parkinson Disease · China3CompletedUCBMay 2014249
NCT01646255Parkinson Disease · China3CompletedUCBOct 2014346
NCT01634243Parkinson Disease · Japan2CompletedOtsukaMay 200664
NCT01631825Parkinson Disease · Japan3CompletedOtsukaJun 2012321
NCT01631812Parkinson Disease · Japan2CompletedOtsukaFeb 2010130
NCT01628965Parkinson Disease · Japan3CompletedOtsukaOct 2010143
NCT01628926Parkinson Disease · Japan3CompletedOtsukaMay 2011420
NCT01628848Parkinson Disease · Japan2CompletedOtsukaApr 2008174
NCT01569464Restless Legs Syndrome · United States3CompletedUCBApr 2013150
NCT01565018Healthy Volunteers · Germany1CompletedUCBJul 201255
NCT01562743Idiopathic Restless Legs Syndrome2CompletedOtsukaOct 2010185
NCT01537042Restless Legs Syndrome · United States, Austria, Finland and more3CompletedUCBOct 201330
NCT01536015Advanced Parkinson's Disease · United States3TerminatedUCBOct 201325
NCT01523301Parkinson Disease · Korea, Republic of4CompletedUCBOct 2014380
NCT01498120Restless Legs Syndrome · United States2CompletedUCBDec 201514
NCT01495793Restless Legs Syndrome · United States2CompletedUCBMay 201442
NCT01455012Restless Legs Syndrome · Germany4CompletedUCBMay 201281
NCT01338896Parkinson Disease · Austria, Germany, United Kingdom1CompletedUCBMay 201156
NCT01300819Parkinson Disease · Austria, Belgium, Bulgaria and more4CompletedUCBOct 2012349
NCT01084551Idiopathic Restless Legs Syndrome · Japan3CompletedOtsukaSep 2011284
NCT01059903Healthy Volunteers · Germany1CompletedUCBFeb 201050
NCT00957944Healthy Volunteers · Germany1CompletedUCBAug 200940
NCT00881894Healthy · Germany1CompletedUCBNov 200852
NCT00666965Idiopathic Restless Legs Syndrome · Japan2CompletedOtsukaAug 2009230
NCT00599196Early Stage Parkinson's Disease · Australia, Austria, Belgium and more3CompletedUCBDec 2008381
NCT00594386Parkinson Disease · United States, Canada3CompletedUCBDec 2008258
NCT00594165Parkinson Disease · United States, Canada3CompletedUCBNov 2008217
NCT00594464Parkinson Disease · Germany4CompletedUCBMay 200814
NCT00593606Parkinson Disease3CompletedUCBDec 2007124
NCT00537485Parkinson Disease · Japan3CompletedOtsukaDec 2009180
NCT00522379Parkinson Disease · United States, Chile, India and more3CompletedUCBJul 2011514
NCT00519532Parkinson Disease · United States, Australia, Finland and more3TerminatedUCBMay 200984
NCT00505687Parkinson Disease · United States, Austria, Germany and more3CompletedUCBDec 2008186
NCT00501969Advanced Stage Parkinson's Disease · Australia, Austria, Croatia and more3CompletedUCBDec 2008395
NCT00498186Restless Legs Syndrome · Austria, Germany, Spain2CompletedUCBApr 2009295
NCT00498108Restless Legs Syndrome · Germany3CompletedUCBSep 2007341
NCT00474058Parkinson Disease · United States, Australia, Austria and more3CompletedUCBMar 2009287
NCT00464737Fibromyalgia · United States2CompletedUCBNov 2008230
NCT00389831Restless Legs Syndrome · Germany2CompletedUCBNov 200644
NCT00296192Parkinson Disease2CompletedUCBJun 200682
NCT00292227Parkinson Disease · South Africa1CompletedUCBSep 2006130
NCT00275236Restless Legs Syndrome · Germany3CompletedUCBJul 200660
NCT00263068Restless Legs Syndrome · United States3CompletedUCBDec 2007279
NCT00244387Parkinson Disease · Germany3CompletedUCBJul 2005506
NCT00243971Parkinson Disease · Germany3CompletedUCBOct 2005
NCT00243945Parkinson Disease · Germany3CompletedUCBJul 200558

How it is read

Names in the registry

  • “Rotigotine”, 39 entries
  • “SPM 962”, 13 entries
  • “Rotigotine transdermal patch”, 4 entries
  • “Rotigexole 8 mg”, 1 entry
  • “Rotigotine 1 mg/24 h”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.